Potential involvement of protein phosphatase 2A in temsirolimus-mediated resensitization to cetuximab in colon cancer cells.
Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, 28040, Madrid, Spain, ion.cristobal@fjd.es.
Ion
I
Cristóbal
Rebeca
R
Manso
Raúl
R
Rincón
Juan
J
Madoz-Gúrpide
Cristina
C
Caramés
Federico
F
Rojo
Jesús
J
García-Foncillas
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001324:Autoantigens / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*
D001324:Autoantigens; D014408:Biomarkers, Tumor; D008565:Membrane Proteins